TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

124.00$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement INSM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
291.6% 24.6% 17.7% 24.3% 23.4% 22.5% 21.5% 23.6% 20.6%
-191.6% 75.4% 82.3% 75.7% 76.6% 77.5% 78.5% 76.4% 79.4%
489.5% 1,477.2% 96.5% 110.2% 144.7% 162.0% 187.1% 164.5% 127.2%
270.2% 1,710.4% 154.5% 123.8% 124.3% 108.3% 112.9% 126.8% 115.6%
759.7% 3,200.3% 254.6% 237.1% 275.6% 263.9% 311.0% 317.9% 273.5%
-759.7% -3,124.9% -172.4% -161.3% -199.0% -186.4% -232.5% -241.5% -194.0%
21.0% 259.0% 20.3% 18.0% 21.5% 10.8% 26.8% 23.3% 13.8%
-779.0% -3,295.1% -185.8% -178.0% -231.6% -195.7% -244.8% -250.2% -209.7%
-90.6% 2.0% 0.6% 0.9% -0.9% 0.6% 0.8% 1.0% 0.8%
-688.3% -3,297.2% -186.4% -178.9% -230.6% -196.3% -245.6% -251.2% -210.5%
-748.6% -3,001.3% -159.1% -152.3% -203.6% -182.3% -216.3% -225.1% -193.2%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?